Toggle light / dark theme

‘Alexa, Titrate My Insulin’: AI App Boosts Glycemic Control in Randomized Trial

Beyond glycemic benefits, users of the app also reported significantly less-related emotional distress than standard care (−1.9 vs 1.7 points in composite survey scores, P =0.03).

“We are currently working on making technology like this accessible to patients outside of research settings because we think it can really help patients in underserved areas who need high-touch care to get their under control,” Nayak said.

The researchers developed their custom voice-based AI app and had it powered by Alexa (Amazon wasn’t involved with the study). The software was equipped with titration algorithms by the American Association of Clinical Endocrinologists and the American College of Endocrinology and included emergency protocols to handle hypoglycemia and hyperglycemia.

The Data Storage of Tomorrow — Scientists Make Supramolecular Breakthrough

In the era of big data and advanced artificial intelligence, traditional data storage methods are becoming inadequate. To address the need for high-capacity and energy-efficient storage solutions, the development of next-generation technologies is crucial.

Among these is resistive random-access memory (RRAM), which relies on altering resistance levels to store data. A recent study published in the journal Angewandte Chemie details the work of a research team who have pioneered a method for creating supramolecular memristors, one of the key components in the construction of nano-RRAM.

Elon Musk’s Latest Update on Tesla’s Full Self-Driving Tech

Elon Musk discusses the progress and challenges of Tesla’s full self-driving technology, expressing less optimism about its timeline but recognizing its potential value and impact on the future of transportation.

Questions to spark discussion.

What is the status of Tesla’s full self-driving technology?
—Elon Musk expects a delay in the release of the new version of Full Self Driving, but believes it will learn dramatically faster.

Implementing AI? Healthcare organizations ‘must have a specific measurable goal’

Panelists include Albert Marinez, chief analytics officer at the Cleveland Clinic; Tatyana Fedotova, director, global data, platforms and partnerships, at Johnson & Johnson; and Christopher Larkin, chief technology officer at Concord Technologies.

Panelists will reveal the most critical questions to ask and decisions to be made at each phase of the AI journey, from build versus buy and tool selection to ensuring AI investments are targeted for maximum impact, and much more.

Google is reportedly pushing the launch of its Gemini AI to 2024

Supposedly only til next month, Jan. 2024. But, it is why we absolutely must keep heat on full acceleration of AI. There is a clear camp wants to stop it, turn it off and walk it a decade backwards. And that is unacceptable.


A new report by The Information says Google has pushed back the launch of its next-gen AI, Gemini. The company was reportedly planning to introduce the new foundational model in events scheduled for next week, but has quietly delayed it until January after finding it needed to work on its responses to non-English queries.

/* */